Skip to main content
. 2023 Mar 29;9(13):eade8778. doi: 10.1126/sciadv.ade8778

Table 3. Resistance phenotypes of Mpro variants in replication-competent SARS-CoV-2.

Mpro variant Nirmatrelvir Ensitrelvir Remdesivir
IC50 nM (95% CI) IC50 nM (95% CI) IC50 μM (95% CI)
WT 4.4 (3.4–5.5) 4.3 (2.9–5.8) 1.2 (0.59–2.5)
∆P168 7.0 (4.1–10.2) 3.6 (2.7–4.4) 1.1 (0.59–2.0)
A173V 36.0 (29.8–43.0) 7.8 (6.2–9.5) 1.3 (0.85–2.1)
∆P168/A173V 275 (161–465) 3.3 (2.1–4.8) 1.5 (0.78–2.9)